Severe asthma with viral infection can develop into eosinophilic granulomatosis with polyangiitis

被引:2
|
作者
Ou, Changxing [1 ]
Ma, Jianjuan [1 ,2 ]
Lai, Ning [1 ]
Li, You [1 ]
Xie, Jiaxing [1 ]
Zhang, Xueyan [3 ]
Zhang, Qingling [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,Natl Ctr Resp Med,State, Guangzhou, Guangdong, Peoples R China
[2] Guizhou Med Univ, Affiliated Hosp, Dept Pediat Hematol, Guiyang, Guizhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 2, Sch Basic Med Sci, State Key Lab Resp Dis,Guangdong Prov Key Lab Alle, Guangzhou, Guangdong, Peoples R China
来源
关键词
severe asthma; eosinophilic granulomatosis with polyangiitis; clinical presentation; triggers; viral infection; CHURG-STRAUSS-SYNDROME; RECOMMENDATIONS; VASCULITIDES; NOMENCLATURE; MONTELUKAST;
D O I
10.2478/rir-2021-0034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Asthma is common in eosinophilic granulomatosis with polyangiitis (EGPA), and the annual incidence of EGPA in patients with asthma is much higher compared with the general population, and the trigger factor for this is unknown. We report a case of a 19-year-old male with a background of severe asthma who presented with eosinophilic lung infiltration after viral infection, which progressed to clinical EGPA. The diagnosis of EGPA was supported by an initial clinical presentation of recurrent cough and wheezing accompanied by a red rash, followed by peripheral eosinophilia, a high eosinophil percentage in bronchoalveolar lavage fluid (BALF), and migratory pulmonary eosinophilic infiltrates. Lung biopsy showed blood vessels with extravascular eosinophils. The patient responded well to high-dose glucocorticoids and cyclophosphamide, and symptoms and biochemical markers improved. Our literature review identified few reports on the triggers of EGPA, which highlights that viral infection may be a risk factor for asthma that progresses to EGPA.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [1] Characteristics of Severe Asthma Clinic Patients With Eosinophilic Granulomatosis With Polyangiitis
    Puan, Youxin
    Ong, Kheng Yong
    Tiew, Pei Yee
    Chen, Gabriel Xu Wen
    Teo, Neville Wei Yang
    Low, Andrea Hsiu Ling
    Wechsler, Michael E.
    Koh, Mariko Siyue
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02):
  • [2] Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab
    Hocevar, Alojzija
    Kopac, Peter
    Rotar, Ziga
    Novljan, Martina Plesivcnik
    Skrgat, Sabina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (07): : 2448 - 2449
  • [3] Eosinophilic Granulomatosis With Polyangiitis Sine Asthma
    Parperis, Konstantinos
    Stanford, Ray
    Isfahani, Firoozeh
    Chebbo, Ahmad
    Chhaya, Sheetal
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (02): : E3 - E3
  • [4] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [5] Severe Eosinophilic Asthma or Eosinophilic Granulomatosis With Polyangiitis: Potential Biomarkers for Novel Diagnostic Strategies
    Latorre, Manuela
    Seccia, Veronica
    Puxeddu, Ilaria
    Pisani, Francesco
    Statuti, Erica
    Cristofani-Mencacci, Lodovica
    Celi, Alessandro
    Cianchetti, Silvana
    Cardini, Cristina
    Di Carluccio, Eleonora
    Ferro, Francesco
    Paggiaro, Pierluigi
    Baldini, Chiara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (11): : 3057 - 3067
  • [6] Mepolizumab and Benralizumab: new therapeutic perspectives for Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
    Scarano, Paola
    Cisternino, Cecilia
    Lo Muzio, Giulia
    Calo, Olimpia
    Sanna, Arianna
    Steffanina, Alessia
    De Filippis, Francesca
    Leporini, Maria Teresa
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
    Martinez-Rivera, Carlos
    Garcia-Olive, Ignasi
    Urrutia-Royo, Blanca
    Basagana-Torrento, Maria
    Rosell, Antoni
    Abad, Jorge
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [8] Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
    Carlos Martínez-Rivera
    Ignasi Garcia-Olivé
    Blanca Urrutia-Royo
    Maria Basagaña-Torrento
    Antoni Rosell
    Jorge Abad
    BMC Pulmonary Medicine, 21
  • [9] Asthma in Eosinophilic Granulomatosis with Polyangiitis Treated with Rituximab
    Moura, Marta Casal
    Berti, Alvise
    Keogh, Karina
    Volcheck, Gerald
    Specks, Ulrich
    Bagir, Misbah
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] Diagnosis and management of Eosinophilic Granulomatosis With Polyangiitis: Perspective from the Severe Asthma Clinic
    Puan, Y.
    Tiew, P. Y.
    Ong, K. Y.
    Koh, M. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60